About QRL Bioscience
QRL Bioscience is a company based in Ahmedabad (India) founded in 2021 by Kranti Vora, Senthil Natesan, and Sanjoy Bhagat. QRL Bioscience has raised $341.58 thousand across 1 funding round from investors including Gujarat Venture Finance. QRL Bioscience offers products and services including QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and Immunophenotyping of Cells. QRL Bioscience operates in a competitive market with competitors including Helsinn, Aster Insights, Abogen Biosciences, OnCusp and CancerVax, among others.
- Headquarter Ahmedabad, India
- Founders Kranti Vora, Senthil Natesan, Sanjoy Bhagat
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qrl Bioscience Private Limited
- Date of Incorporation 16 Apr, 2023
- Jurisdiction Gandhinagar, Gujarat, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$341.58 K (USD)
in 1 rounds
-
Latest Funding Round
$341.58 K (USD), Seed
Aug 06, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QRL Bioscience
QRL Bioscience offers a comprehensive portfolio of products and services, including QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and Immunophenotyping of Cells.
Autologous therapy for chronic non-healing wounds
Product for additional chronic conditions
Therapy targeting degenerative diseases
Manufacturing of cell-based therapeutic products
Analysis service for cell characteristics
Testing for cell-based immune responses
Funding Insights of QRL Bioscience
QRL Bioscience has successfully raised a total of $341.58K through 1 strategic funding round. The most recent funding activity was a Seed round of $341.58 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in QRL Bioscience
QRL Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gujarat Venture Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in Indian startups across multiple sectors.
|
Locked | Locked | Locked |
Investor details for QRL Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QRL Bioscience
Investment portfolio details for QRL Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - QRL Bioscience
Detailed financials for QRL Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qrl Bioscience Comparisons
Peer comparison for QRL Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QRL Bioscience
QRL Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, Abogen Biosciences, OnCusp and CancerVax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| Locked | Locked | Locked |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| Locked | Locked | Locked |
CRO offering clinical development services for oncology drugs
|
|
| Locked | Locked | Locked |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| Locked | Locked | Locked |
Full-service CRO operations are conducted across more than 20 countries.
|
Detailed competitors of QRL Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qrl Bioscience
Complete news archive for QRL Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QRL Bioscience
QRL Bioscience was founded in 2021 and raised its 1st funding round 4 years after it was founded.
QRL Bioscience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
QRL Bioscience is a funded company, having raised a total of $341.58K across 1 funding round to date.
QRL Bioscience cro focused on cancer cell based clinical trial services, focusing on providing healthcare solutions, biopharma outsourcing, cro, clinical development, full service, and oncology. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
QRL Bioscience offers QRLBIO001, QRLBIO002, QRLBIO003, Cell Therapy Manufacturing, and 2 more products and services.
QRL Bioscience has 1 investor. Key investors include Gujarat Venture Finance.